Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Jacobson

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|October 3, 2000
"The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?T A Jacobson
Lancet (London, England)|July 15, 1995
Implications of 4S evidence on baseline lipid levelsT A Jacobson
Current Opinion in Lipidology|December 31, 1997
Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart diseaseT A Jacobson
Current Atherosclerosis Reports|August 7, 2001
Combination lipid-altering therapy: an emerging treatment paradigm for the 21st centuryT A Jacobson
JAMA|August 11, 1989
Quitting smoking: nicotine vs placebo gumT A Jacobson
Annals of Internal Medicine|November 1, 1988
Chronic hepatitis BT A Jacobson
International Journal of Clinical Practice|November 26, 2010
'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemiaT A Jacobson
The American Journal of Cardiology|September 26, 1996
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor therapy in the managed care eraT A Jacobson
The American Journal of Medicine|April 20, 2001
Clinical context: current concepts of coronary heart disease managementT A Jacobson
The American Journal of Medicine|April 20, 2001
Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. IntroductionT A Jacobson
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|October 3, 2000
"The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?T A Jacobson
Lancet (London, England)|July 15, 1995
Implications of 4S evidence on baseline lipid levelsT A Jacobson
Current Opinion in Lipidology|December 31, 1997
Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart diseaseT A Jacobson
Current Atherosclerosis Reports|August 7, 2001
Combination lipid-altering therapy: an emerging treatment paradigm for the 21st centuryT A Jacobson
JAMA|August 11, 1989
Quitting smoking: nicotine vs placebo gumT A Jacobson
Annals of Internal Medicine|November 1, 1988
Chronic hepatitis BT A Jacobson
International Journal of Clinical Practice|November 26, 2010
'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemiaT A Jacobson
The American Journal of Cardiology|September 26, 1996
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor therapy in the managed care eraT A Jacobson
The American Journal of Medicine|April 20, 2001
Clinical context: current concepts of coronary heart disease managementT A Jacobson
The American Journal of Medicine|April 20, 2001
Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. IntroductionT A Jacobson
Pageof 3